title: Update of faecal markers of inflammation in children with cystic fibrosis.
abstract: There is evidence of intestinal inflammation in patients with CF. Intestinal inflammation may negatively impact the nutritional status of patient with CF, which adversely affects pulmonary function and survival. This paper provides an up-to-date review of intestinal inflammation in CF and an evaluation of utility of two specific faecal inflammatory markers (S100A12 and calprotectin).
authors.affiliation: School of Women's and Children's Health, Faculty of Medicine, University of New South Wales, High Street, Sydney, NSW, Australia.
authors.forename: Jung M
authors.initials: JM
authors.lastname: Lee
authors.forename: Steven T
authors.initials: ST
authors.lastname: Leach
authors.forename: Tamarah
authors.initials: T
authors.lastname: Katz
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Day
authors.forename: Adam
authors.initials: A
authors.lastname: Jaffe
authors.forename: Chee Y
authors.initials: CY
authors.lastname: Ooi
mesh_terms: D015415:Biomarkers / Q000378:metabolism*; D003550:Cystic Fibrosis / Q000276:immunology* / Q000378:metabolism*; D005243:Feces / Q000737:chemistry*; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000378:metabolism*; D039841:Leukocyte L1 Antigen Complex / Q000378:metabolism; D009418:S100 Proteins / Q000378:metabolism; D000067616:S100A12 Protein
chemical_list: D015415:Biomarkers; D039841:Leukocyte L1 Antigen Complex; D009418:S100 Proteins; D000067616:S100A12 Protein; C090441:S100A12 protein, human